drugset
drugset / Trial / NCT01017666

BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

NCT01017666 ↗

Phase 1 Completed 28 enrolled Biogen
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to understand whether BIIB014 has potential to affect how certain drugs are broken down by the body.

Timeline

Start
2009-11-01
Primary completion
2010-06-02
Completion
2010-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject VIPADENANT Small molecule 100 mg Oral

Indications

No indication recorded.